Reactor Thoracostomy (UNCUT)
Use of a Novel Chest Tube Insertion Device for Urgent Thoracostomy in an Emergency Department Setting
Sponsor: Crozer-Keystone Health System
Listed as NCT03734471, this PHASE3 trial focuses on Hemothorax and Pneumothorax and remains ongoing. Sponsored by Crozer-Keystone Health System, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
-
Feb 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Dec 2018 — Feb 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Crozer-Keystone Health System
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.